secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hims & Hers Health, Inc. (HIMS)
CIK:        0001773751
Form:       8-K
Filed at:   2026-05-19T12:17:31+00:00
Accession:  0001193125-26-229749
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hims & Hers prices $350M 0.00% convertible notes due 2032; funds Eucalyptus acquisition & AI
--------------------------------------------------------------------------------

- Offering upsized from $300M to $350M; initial purchasers can buy additional $52.5M.
- Notes mature June 1, 2032; zero coupon; initial conversion price ~$29.53/share (32.5% premium over $22.29 close).
- Net proceeds ~$338.5M; $32M for capped call transactions; remainder for international expansion, including Eucalyptus acquisition, AI, and infrastructure.
- Capped call transactions reduce dilution, cap price initially ~$50.15/share.
- Settlement expected May 21, 2026; Eucalyptus acquisition expected mid-2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1773751/000119312526229749/0001193125-26-229749-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1773751/000119312526229749/d227898d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-229749

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer